A new standard of care for treatment of ovarian cancer

Eur J Cancer. 2000 Jan;36(1):10-2. doi: 10.1016/s0959-8049(99)00210-5.
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carboplatin / administration & dosage
  • Cisplatin / administration & dosage
  • Female
  • Humans
  • Ovarian Neoplasms / drug therapy*
  • Paclitaxel / administration & dosage
  • Quality of Health Care
  • Randomized Controlled Trials as Topic
  • Survival Analysis

Substances

  • Carboplatin
  • Paclitaxel
  • Cisplatin